Moreover, it has been observed that anti-TNF-α antibodies can prevent death of RGCs by reducing ocular hypertension, suggesting that reducing the expression of TNF-α would be beneficial in treating glaucoma [14]. The gene discussed is TNF; the disease is glaucoma.